F-092IMPACT OF PATIENT SELECTION AND TREATMENT STRATEGIES ON OUTCOMES AFTER LOBECTOMY FOR BIOPSY-PROVEN STAGE IIIA pN2 NON-SMALL CELL LUNG CANCER

Chi-Fu Jeffrey Yang; R.R. Meyerhoff; K.L. Anderson; S. Adil; M. Hartwig; D. Harpole; T. D'Amico; M. Berry

doi:10.1093/icvts/ivv204.92

F-092IMPACT OF PATIENT SELECTION AND TREATMENT STRATEGIES ON OUTCOMES AFTER LOBECTOMY FOR BIOPSY-PROVEN STAGE IIIA pN2 NON-SMALL CELL LUNG CANCER

Interactive CardioVascular and Thoracic Surgery ◽

10.1093/icvts/ivv204.92 ◽

2015 ◽

Vol 21 (suppl_1) ◽

pp. S26-S26

Author(s):

Chi-Fu Jeffrey Yang ◽

R.R. Meyerhoff ◽

K.L. Anderson ◽

S. Adil ◽

M. Hartwig ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Patient Selection ◽

Cell Lung Cancer ◽

Treatment Strategies ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia

Download Full-text

Faculty Opinions recommendation of Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726048260.793512851 ◽

2016 ◽

Author(s):

Paul Van Schil

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Patient Selection ◽

Cell Lung Cancer ◽

Treatment Strategies ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia

Download Full-text

Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer

European Journal of Cardio-Thoracic Surgery ◽

10.1093/ejcts/ezv431 ◽

2015 ◽

Vol 49 (6) ◽

pp. 1607-1613 ◽

Cited By ~ 15

Author(s):

Chi-Fu Jeffrey Yang ◽

Syed M. Adil ◽

Kevin L. Anderson ◽

Robert Ryan Meyerhoff ◽

Ryan S. Turley ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Patient Selection ◽

Cell Lung Cancer ◽

Treatment Strategies ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia

Download Full-text

CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer

Case Medical Research ◽

10.31525/ct1-nct04062708 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitor ◽

Checkpoint Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia

Download Full-text

Faculty Opinions recommendation of The Optimal Treatment for Stage IIIA-N2 Non-small-cell Lung Cancer: A Network Meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734650086.793556621 ◽

2019 ◽

Author(s):

Paul Van Schil

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Optimal Treatment ◽

Small Cell Lung ◽

Stage Iiia

Download Full-text

Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies

Current Clinical Pharmacology ◽

10.2174/1574884711666160502124134 ◽

2016 ◽

Vol 11 (2) ◽

pp. 77-87 ◽

Cited By ~ 10

Author(s):

Francesca Casaluce ◽

Assunta Sgambato ◽

Paola Sacco ◽

Giovanni Palazzolo ◽

Paolo Maione ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Targeted Therapies ◽

Treatment Strategies ◽

Small Cell ◽

Small Cell Lung ◽

Alk Rearrangement

Download Full-text

Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non–Small-Cell Lung Cancer

Journal of Oncology Practice ◽

10.1200/jop.18.00127 ◽

2018 ◽

Vol 14 (9) ◽

pp. 569-571 ◽

Cited By ~ 1

Author(s):

Addie Hill ◽

Jun Gong ◽

Sharon Wilczynski ◽

Rizvan Mirza ◽

Loretta Erhunmwunsee ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Pathologic Response ◽

Complete Pathologic Response ◽

Small Cell Lung ◽

Stage Iiia

Download Full-text

Corrigendum to “Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach”

Therapeutic Advances in Medical Oncology ◽

10.1177/17588359211034059 ◽

2021 ◽

Vol 13 ◽

pp. 175883592110340

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Clinical Impact ◽

Small Cell Lung ◽

Stage Iiia ◽

Immune Microenvironment ◽

Tumor Immune Microenvironment ◽

Resected Stage

Download Full-text

P20.02 To Evaluate the Efficacy and Optimal Timing of Postoperative Radiotherapy in Completely Resected stage IIIA(N2) Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.576 ◽

2021 ◽

Vol 16 (3) ◽

pp. S360-S361

Author(s):

W. Feng ◽

X. Fu ◽

X. Cai ◽

J. Liu ◽

D. Hu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Postoperative Radiotherapy ◽

Small Cell ◽

Optimal Timing ◽

Small Cell Lung ◽

Stage Iiia ◽

Resected Stage

Download Full-text

Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-Small Cell Lung Cancer: SQUAT trial (WJOG 12119L)

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.04.006 ◽

2021 ◽

Author(s):

Akira Hamada ◽

Junichi Soh ◽

Akito Hata ◽

Kiyoshi Nakamatsu ◽

Mototsugu Shimokawa ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia ◽

Adjuvant Immunotherapy

Download Full-text

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy stage IIIA-N2 non-small-cell lung cancer

Cancer/Radiothérapie ◽

10.1016/j.canrad.2008.03.003 ◽

2008 ◽

Vol 12 (5) ◽

pp. 500-501

Keyword(s):

Lung Cancer ◽

Randomized Controlled Trial ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia ◽

Randomized Controlled

Download Full-text